91 related articles for article (PubMed ID: 8050552)
21. [Two cases of amylase-producing lung cancer].
Kamio T; Sameshima K; Irie J; Shigematsu K; Kawai K; Tsuchiyama H; Nakano M
Gan No Rinsho; 1989 May; 35(6):735-40. PubMed ID: 2470931
[TBL] [Abstract][Full Text] [Related]
22. A case of amylase-producing lung cancer.
Tsukawaki M; Izawa M; Yoshida M; Araki N; Hashiba Y; Nakagawa H; Momose M; Kawase S; Tominaga J; Kawai S
Intern Med; 1992 Jan; 31(1):60-3. PubMed ID: 1373662
[TBL] [Abstract][Full Text] [Related]
23. Immunochemical analysis of cathepsin B in lung tumours: an independent prognostic factor for squamous cell carcinoma patients.
Werle B; Lötterle H; Schanzenbächer U; Lah TT; Kalman E; Kayser K; Bülzebruck H; Schirren J; Krasovec M; Kos J; Spiess E
Br J Cancer; 1999 Oct; 81(3):510-9. PubMed ID: 10507778
[TBL] [Abstract][Full Text] [Related]
24. Establishment and characterization of amylase-producing lung adenocarcinoma cell line, IMEC-2.
Yokouchi H; Yamazaki K; Asahina H; Shigemura M; Moriyama T; Takaoka K; Moriya J; Itoh T; Kinoshita I; Dosaka-Akita H; Tsutsumi Y; Nishimura M
Anticancer Res; 2006; 26(4B):2821-7. PubMed ID: 16886600
[TBL] [Abstract][Full Text] [Related]
25. Differences in metabolism between adeno- and squamous cell non-small cell lung carcinomas: spatial distribution and prognostic value of GLUT1 and MCT4.
Meijer TW; Schuurbiers OC; Kaanders JH; Looijen-Salamon MG; de Geus-Oei LF; Verhagen AF; Lok J; van der Heijden HF; Rademakers SE; Span PN; Bussink J
Lung Cancer; 2012 Jun; 76(3):316-23. PubMed ID: 22153830
[TBL] [Abstract][Full Text] [Related]
26. An immunohistochemical study of lung carcinomas using a monoclonal antibody which specifically reacts to basal cells.
Maeda K; Sueishi K
Mod Pathol; 1990 Jan; 3(1):43-8. PubMed ID: 2155419
[TBL] [Abstract][Full Text] [Related]
27. Large cell carcinoma of the lung--ultrastructural and immunohistochemical studies.
Kodama T; Shimosato Y; Koide T; Watanabe S; Teshima S
Jpn J Clin Oncol; 1985 Jun; 15(2):431-41. PubMed ID: 2410641
[TBL] [Abstract][Full Text] [Related]
28. Caveolins as tumour markers in lung cancer detected by combined use of cDNA and tissue microarrays.
Wikman H; Seppänen JK; Sarhadi VK; Kettunen E; Salmenkivi K; Kuosma E; Vainio-Siukola K; Nagy B; Karjalainen A; Sioris T; Salo J; Hollmén J; Knuutila S; Anttila S
J Pathol; 2004 May; 203(1):584-93. PubMed ID: 15095482
[TBL] [Abstract][Full Text] [Related]
29. Multiple myeloma associated with sialyl salivary-type amylase.
Shigemura M; Moriyama T; Shibuya H; Obara M; Endo T; Hashino S; Yokouchi H; Asaka M; Shimizu C; Chiba H; Nishimura M
Clin Chim Acta; 2007 Feb; 376(1-2):121-5. PubMed ID: 16979610
[TBL] [Abstract][Full Text] [Related]
30. High-grade neuroendocrine carcinoma of the lung shows increased thymidylate synthase expression compared to other histotypes.
Ibe T; Shimizu K; Nakano T; Kakegawa S; Kamiyoshihara M; Nakajima T; Kaira K; Takeyoshi I
J Surg Oncol; 2010 Jul; 102(1):11-7. PubMed ID: 20578072
[TBL] [Abstract][Full Text] [Related]
31. [The expression and clinical significance of AKT2, phosphorylated AKT2 in non-small cell lung cancer].
Pu R; Li WM; Liu D; Mo XM; Tang Y; Liu LX; Chen BJ
Sichuan Da Xue Xue Bao Yi Xue Ban; 2010 Jul; 41(4):586-9. PubMed ID: 20848774
[TBL] [Abstract][Full Text] [Related]
32. Comprehensive histologic analysis of ALK-rearranged lung carcinomas.
Yoshida A; Tsuta K; Nakamura H; Kohno T; Takahashi F; Asamura H; Sekine I; Fukayama M; Shibata T; Furuta K; Tsuda H
Am J Surg Pathol; 2011 Aug; 35(8):1226-34. PubMed ID: 21753699
[TBL] [Abstract][Full Text] [Related]
33. Immunohistochemical expression of aminopeptidase N (CD13) in human lung squamous cell carcinomas, with special reference to Bestatin adjuvant therapy.
Ichimura E; Yamada M; Nishikawa K; Abe F; Nakajima T
Pathol Int; 2006 Jun; 56(6):296-300. PubMed ID: 16704492
[TBL] [Abstract][Full Text] [Related]
34. Immunohistochemical expression of cyclooxygenase isoenzymes and downstream enzymes in human lung tumors.
Ermert L; Dierkes C; Ermert M
Clin Cancer Res; 2003 May; 9(5):1604-10. PubMed ID: 12738712
[TBL] [Abstract][Full Text] [Related]
35. [Immunohistochemical investigation on the expression of glutathione S-transferases (GSTS) in lung cancer].
Nie KR; Li CH; Zhu YJ
Zhonghua Jie He He Hu Xi Za Zhi; 1993 Jun; 16(3):141-3, 186. PubMed ID: 8242809
[TBL] [Abstract][Full Text] [Related]
36. Fuzzy logic-based tumor marker profiles including a new marker tumor M2-PK improved sensitivity to the detection of progression in lung cancer patients.
Schneider J; Peltri G; Bitterlich N; Neu K; Velcovsky HG; Morr H; Katz N; Eigenbrodt E
Anticancer Res; 2003; 23(2A):899-906. PubMed ID: 12820320
[TBL] [Abstract][Full Text] [Related]
37. Analysis of the prognostic impact of nestin expression in non-small cell lung cancer.
Skarda J; Kolar Z; Janikova M; Radova L; Kolek V; Fridman E; Kopolovic J
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2012 Jun; 156(2):135-42. PubMed ID: 22837134
[TBL] [Abstract][Full Text] [Related]
38. Expression of CEA and trophoblastic cell markers by lung carcinoma in association with histological characteristics and serum marker levels.
Slodkowska J; Szturmowicz M; Rudzinski P; Giedronowicz D; Sakowicz A; Androsiuk W; Zakrzewska-Rowinska E
Eur J Cancer Prev; 1998 Feb; 7(1):51-60. PubMed ID: 9511851
[TBL] [Abstract][Full Text] [Related]
39. [Histocytospectrophotometric characteristics of lung cancer].
Kudriavtsev IuV
Arkh Patol; 1980; 42(11):20-7. PubMed ID: 6255907
[TBL] [Abstract][Full Text] [Related]
40. Identification of alpha-enolase as an autoantigen in lung cancer: its overexpression is associated with clinical outcomes.
Chang GC; Liu KJ; Hsieh CL; Hu TS; Charoenfuprasert S; Liu HK; Luh KT; Hsu LH; Wu CW; Ting CC; Chen CY; Chen KC; Yang TY; Chou TY; Wang WH; Whang-Peng J; Shih NY
Clin Cancer Res; 2006 Oct; 12(19):5746-54. PubMed ID: 17020980
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
